Investor Relations

Latest News

ASP Isotopes Inc. Announces Closing of an Additional Offering of Convertible Notes by Quantum Leap Energy

Read Press Release

ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases

Read Press Release

ASP Isotopes Issues Letter to Stockholders

Read Press Release

Latest Presentation

Company Presentation

Latest Event

Annual Meeting of Stockholders

Latest Financial Results

Q1 2024

Quarter Ended Mar 31, 2024

Latest Annual Filing

For Fiscal Year Ending December 31, 2023

Company Overview

ASP is an advanced materials company dedicated to developing technology and processes designed to produce and enrich isotopes used in multiple markets, which include Nuclear Medicine and therapeutics, green energy generation, and quantum computing.

Our initial focus is to utilize our proprietary ASP technology to construct, commission, and later produce commercial amounts of highly enriched isotopes for the Nuclear medicine market at our plants located in South Africa. We believe that the isotopes we may develop using the ASP technology have significant potential advantages to the end user, as well as commercial advantages due to companies’ Modular, cost-effective, and environmentally friendly processes.

We may also seek to use the ASP technology to separate other isotopes in the future, which we believe have potential applications in the quantum computing target end market and nuclear green energy end market.

We were incorporated in Delaware in September 2021. Our principal executive offices are located at 1101 Pennsylvania Avenue NW, Suite 300, Washington, DC 20004, and our website address is

Stock Snapshot

IR Contacts


ASP Isotopes Inc.
1101 Pennsylvania Avenue NW
Suite 300
Washington DC 20004
United States

Investor Relations

Jason Assad
T: 561-709-3043

Transfer Agent

American Stock Transfer & Trust Company, LLC
6201 15th Ave
Brooklyn NY 11219
United States
T: 800-937-5449